Bulletin
Investor Alert

Rafael Holdings Inc.

NYS: RFL

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Rafael Holdings Inc.

After Hours

 --Quotes are delayed by 20 min

May 18, 2022, 4:00 p.m.

RFL
/zigman2/quotes/206275218/composite

$

1.84

Change

0.00 0.00%

Volume

Volume 745

Quotes are delayed by 20 min

/zigman2/quotes/206275218/composite

Today's close

$ 1.85

$ 1.84

Change

-0.01 -0.54%

Day low

Day high

$1.80

$1.94

Open

52 week low

52 week high

$1.60

$66.44

Open

Company Description

Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. It operates through the Real Estate and Pharmaceuticals segments. The Real Estate segment refers to the real estate holdings. The Pharmaceuticals segment is comprised of debt interests a...

Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. It operates through the Real Estate and Pharmaceuticals segments. The Real Estate segment refers to the real estate holdings. The Pharmaceuticals segment is comprised of debt interests and warrants in Rafael Pharmaceuticals and a majority equity interest in LipoMedix Pharmaceuticals. The company was founded in 2017 and is headquartered in Newark, NJ.

Valuation

Price to Sales Ratio

210.58

Price to Book Ratio

7.34

Enterprise Value to EBITDA

-1.88

Enterprise Value to Sales

9.81

Total Debt to Enterprise Value

0.02

Efficiency

Revenue/Employee

172,652.00

Income Per Employee

-1,067,130.00

Receivables Turnover

5.92

Total Asset Turnover

0.03

Liquidity

Current Ratio

0.85

Quick Ratio

0.85

Cash Ratio

0.74

Profitability

Operating Margin

-574.46

Pretax Margin

-632.86

Net Margin

-618.08

Return on Assets

-16.90

Return on Equity

-20.53

Return on Total Capital

-16.19

Return on Invested Capital

-20.53

Capital Structure

Total Debt to Total Equity

11.88

Total Debt to Total Capital

10.62

Total Debt to Total Assets

9.43

Officers and Executives

Name Age Officer Since Title
Mr. Howard S. Jonas 65 2017 Chairman & Chief Executive Officer
Mr. William Conkling - 2021 Chief Commercial Officer
Mr. Patrick Fabbio 52 2021 Chief Financial Officer
Mr. Gus Kodersha - 2021 Chief Technical Operations Officer
Ms. Melissa Lozner - 2021 Chief Compliance & Ethics Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
02/01/2022 William Conkling
Chief Executive Officer 		623,732   Award at $0 per share. 0
02/01/2022 Patrick Fabbio
CFO & President 		363,103   Award at $0 per share. 0
02/01/2022 Ameet Mallik
Director 		908,497   0
01/19/2022 Stephen M. Greenberg
Director 		7,512   Award at $5.39 per share. 40,489
01/05/2022 Boris C. Pasche
Director 		7,512   Award at $5.39 per share. 40,489
01/05/2022 Mark A. McCamish
Director 		5,412   Award at $5.39 per share. 29,170
01/05/2022 Shannon Thyme Klinger
Director 		5,412   Award at $5.39 per share. 29,170
09/23/2021 David A. Polinsky
Former Chief Financial Officer 		571   Derivative/Non-derivative trans. at $35.77 per share. 20,424
05/27/2021 Ameet Mallik
Director 		908,497   Award at $44.7 per share. 40,609,815
01/19/2021 Michael J. Weiss
Director 		7,512   Award at $5.39 per share. 40,489
01/05/2021 Menachem Ash
President 		5,405   Derivative/Non-derivative trans. at $22.72 per share. 122,801
01/05/2021 Stephen M. Greenberg
Director 		4,203   Award at $22.72 per share. 95,492
01/05/2021 Michael J. Weiss
Director 		4,203   Award at $22.72 per share. 95,492
01/05/2021 Boris C. Pasche
Director 		4,203   Award at $22.72 per share. 95,492
09/23/2020 David A. Polinsky
Former Chief Financial Officer 		5,000   Award at $0 per share. 0
01/24/2020 Menachem Ash
President 		5,238   Derivative/Non-derivative trans. at $22.16 per share. 116,074
01/06/2020 Stephen M. Greenberg
Director 		4,203   Award at $16.68 per share. 70,106
01/06/2020 Michael J. Weiss
Director 		4,203   Award at $16.68 per share. 70,106
01/06/2020 Boris C. Pasche
Director 		4,203   Award at $16.68 per share. 70,106
/news/latest/company/us/rfl

MarketWatch News on RFL

/news/nonmarketwatch/company/us/rfl

Other News on RFL

  1. Tracking Kahn Brothers Portfolio - Q1 2022 Update

    8:57 p.m. May 2, 2022

    - Seeking Alpha

  2. 10-Q: RAFAEL HOLDINGS, INC.

    4:28 p.m. March 17, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. Tracking Kahn Brothers Portfolio - Q4 2021 Update

    10:59 p.m. Jan. 25, 2022

    - Seeking Alpha

  5. Rafael announces CEO transition

    8:20 a.m. Jan. 21, 2022

    - Seeking Alpha

  7. 10-Q: RAFAEL HOLDINGS, INC.

    5:49 p.m. Dec. 15, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  8. In a Bad Year for Biotech Stocks, Deals and Vaccines Were Winners

    3:34 a.m. Dec. 16, 2021

    - The Wall Street Journal Interactive Edition

  9. Rafael Holdings: A Coin Flip

    2:28 p.m. Nov. 18, 2021

    - Seeking Alpha

  12. Tracking Kahn Brothers Portfolio - Q3 2021 Update

    1:00 a.m. Nov. 3, 2021

    - Seeking Alpha

  13. Wall Street Breakfast: What Moved Markets

    8:06 a.m. Oct. 30, 2021

    - Seeking Alpha

  14. TRIT and SYTA among mid-day movers

    1:59 p.m. Oct. 28, 2021

    - Seeking Alpha

  15. Here's Why Rafael Holdings Is Plummeting Today

    11:46 a.m. Oct. 28, 2021

    - Motley Fool

  16. Twilio, eBay, Futu Holdings among premarket losers' pack

    8:27 a.m. Oct. 28, 2021

    - Seeking Alpha

  18. 10-K: RAFAEL HOLDINGS, INC.

    5:07 p.m. Oct. 18, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  21. Loading more headlines...

At a Glance

Rafael Holdings, Inc.

520 Broad Street

Newark, New Jersey 07102

Phone

1 2126581450

Industry

Real Estate Developers

Sector

Real Estate/Construction

Fiscal Year-end

07/2022

View SEC Filings

Revenue

$3.97M

Net Income

$-24.54M

Employees

23.00

Annual Report for RFL

/news/pressrelease/company/us/rfl

Press Releases on RFL

  21. Loading more headlines...
Link to MarketWatch's Slice.